We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Ozempic Novo Nordisk Pharmaceuticals Pty Ltd
Product name
Ozempic
Accepted date
Sep-2024
Active ingredients
Semaglutide
Proposed indication
To reduce the risk of kidney failure.
Application type
C (new indication)
Publication date
Sep-2024